HealthEquity, Inc. (HQY) on Q4 2021 Results - Earnings Call Transcript
Operator: Please go ahead, Mr. Putnam. Richard Putnam: Good afternoon, and welcome to HealthEquity's Fiscal 2021 Earnings Conference Call. My name is Richard Putnam, Investor Relations for HealthEquity. And joining me today is Jon Kessler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the company; Darcy Mott, the company's Executive Vice President and CFO; Tyson Murdock, Executive Vice President and Deputy CFO; and Ted Bloomberg, our Executive Vice President and Chief Operating Officer. Jon Kessler: Thank you, Richard, and in deference to my mother's favorite TV show, You Are My American Idol. Hello, everyone and thank you for joining us this afternoon. Today, we are announcing strong results for HealthEquity's fiscal fourth quarter and for the full fiscal 2021, which ended on January 31st and we're providing guidance for fiscal '22. After briefly touching on our fiscal '21 results, after I do that, Ted will review operations and touch on the recent Luum acquisition. Darcy and Tyson will tag team the financial results, details of fiscal '21 and guidance for fiscal '22 based on the results we're reporting today. And Steve is here to join us for Q&A. Ted Bloomberg: Thanks, Jon. Hello, everybody. We are very pleased with the operating results that we delivered in Q4 and for all of fiscal '21, especially given the very challenging circumstances COVID presented. We are able to make tremendous progress on integrating WageWorks and we found efficiencies that allowed us to raise our synergy target from $50 million to $80 million. With $60 million of run rate synergies achieved to the end of FY '21. We onshored member phone calls, we completed 13 migrations with the heavy focus on HAS, we saw that our member and client experience scores improve. We unified our brand, released the first version of our integrated platform to strong reviews on both portal and mobile and met our service level commitments during this year, as did you see. There's more work to be done however. We're targeting another six migrations this year, along with integration work to support our newest acquisition of Luum. We intend to roll out the next iteration of our integrated platform with features that our clients, members and partners are excited about. As I mentioned in February, our sales results year-to-date remain ahead of where they were last year. We believe this performance can be attributed to market receptiveness of our total solution. The work we have done building strong distribution partnerships, and the incredible work our onboarding teams did making new clients feel the purple love this December in January. We hope to see this positive trend continue as unemployment bottoms out, Americans get vaccinated and clients and members return to work and re-engage with their benefits solutions. Speaking of returning to work, let me share a little bit about our newest teammates or luminaries in Seattle. We are so excited to require Luum to help us drive our commuter benefit beyond monthly transit passes, and help solve real back to work challenges for our clients. The post COVID commute environment will look very different, with employers wanting to deliver flexible benefits and incent employee behaviors to manage tight parking solutions and make better use of alternative transit. Luum can also help companies take basic ESG steps, they have a proven track record of lowering drive alone rates and reducing car trips. We believe in that mission and we believe that Luum will fulfill our commitment to continuously innovate our services to meet the evolving needs of our clients, large and small. Darcy Mott: Thank you, Ted. I will review our fourth quarter GAAP and non-GAAP financial results. A reconciliation of GAAP measures to non-GAAP measures is found in today's press release. Our fiscal fourth quarter financial results as you know include the operations of WageWorks which was acquired in August of 2019 and included five months, including the full fourth quarter of fiscal year 2020. Fourth quarter revenue declined 6% as the economic effects of the pandemic impacted each of our three categories. Service revenue declined 9% to $111.3 million, representing 59% of total revenue in the quarter. The decrease is primarily attributable to 5% decline in CDB accounts at year-end, including an over 50% decrease in commuter, while the growth in Asia helped average total accounts remain flat year-over-year. The full year revenue decreased 2% to $48.6 million in the fourth quarter, representing 26% of revenue in the quarter. The decline was primarily due to 31 basis point decline in the annualized yield on HSA cash with yield assets, partially offset by year-over-year growth of 16% in average HSA cash with yield and 66% growth in average HSA investments with yield. The annualized interest rate yield was 1.97% on HSA cash with yield during the fourth quarter this year. This yield is a blended rate for all HSA cash with yield during the quarter. The HSA assets table of today's press release provides additional details. As previously mentioned, we have migrated 97% of the HSA assets to the HealthEquity custodial platform. Interchange revenue declined 5% to $28.3 million, representing 15% of total revenue in the quarter. The interchange revenue decline was primarily due to reduced spend across our platforms in the quarter. Gross profit was $100.9 million compared to $113.7 million in the fourth quarter of last year. Gross margin was 54% in the quarter. Operating expenses were $100.8 million or 54% of revenue, including amortization of acquired intangible assets and merger integration expenses, which together represented 17% of revenue. Income from operations was $0.1 million compared to $14.5 million in the prior year. Net income for the fourth quarter was $5.4 million or $0.07 per share on a GAAP EPS basis compared to a loss of $0.2 million or a loss of zero cents per share in the prior year. Tyson Murdock: Thanks, Darcy. It's been a pleasure serving with Darcy, and we're all glad he's sticking around to help us with other areas of the company going forward. Darcy makes everyone better when he's around. Based on where we ended fiscal '21 and our current view of the economic environment now expected for fiscal '22, we expect to generate revenue for fiscal '22 in a range between $750 million and $760 million. We expect our non-GAAP net income to be between $115 million and $119 million, resulting in non-GAAP diluted net income between $1.37 and $1.42 per share based upon an estimated 84 million shares outstanding for the year. We expect HealthEquity's adjusted EBITDA to be between $240 million and $246 million for fiscal '22. Today's guidance includes our most recent estimate of service, custodial and interchange revenue based on early fiscal '22 results as well as modest revenue expectations from the acquisition of Luum, and COBRA uptake based on the recent stimulus bill weighted towards the latter part of the year. Guidance also assumes a yield on HSA cash with a yield of approximately 175 basis points as well as the effect of approximately $60 million of achieved run rate synergies had discussed, which will be fully realized in fiscal '22. The outlook for fiscal '22 assumes a projected statutory income tax rate of approximately 25%. As we've done in recent reporting periods, our full year guidance includes a detailed reconciliation of GAAP to the non-GAAP metrics provided in the earnings release, and a definition of all such items is included at the end of the earnings release. In addition, while the amortization of acquired intangibles is being excluded to non-GAAP net income, the revenue generated from those acquired intangible assets is not executed. With that, I'll turn the call back over to Jon for some closing remarks. Thanks. Jon Kessler: Thanks, Tyson, well done. Plus one to Ted. Thanks to the team for a very special year under very unique circumstances. And also to Tyson's, thanks to my friend, Darcy Mott. None of you would ever have heard of HealthEquity and Purple culture certainly would not be as strong and stable without Darcy and his 14 years of service to our team and our mission. When Darcy joined a small team of less than 100 team members here, HealthEquity had a handful of health plan relationships, 20,000 HSA members and all of $20 million of HSA assets. He's remarkable in the truest sense of the word. His wisdom and financial talents turn the company profitable, prepared it for our IPO, grew it to where we stand here. But Darcy is a complicated guy, outwardly mild manner drives the fastest car of the lot. That's true. He's a finance guy through and through, but he's stepping out of the CFO role and signing up to continue to work just as hard at HealthEquity's mission but for less money. Well, I don't know. But I think we've got a great bargain, and all of us truly look forward to continuing to work with Darcy for as long as we can keep them. Thank you, my friend. With that, let's open the call up to questions. Operator? Operator: And we have a question from Greg Peters of Raymond James. GregPeters: Darcy, I guess you're going to be giving up your responsibilities. But I guess remember the next best round of golf is right around the corner. I think it's Ben Hogan had said the most important shot in golf is the next one, and it looks like you’re going to have a lot of opportunities going forward. So I guess I am only allowed to ask one question in one part. So with that, I know you raised the capital, you’ve announced the one transaction. We've been hearing in the marketplace about increased interest from others who are well capitalized, well funded about interest in doing M&A in the space. So the question for you or you Jon and your management team is, do feel like the multiples for deals is moving up, and do you feel like the competition for these deals has increased to the point where maybe some of them will not be as attractive as they once might have been? JonKessler: Well, I guess I would say the way we look at, our plan with regard to the capital that we raised and the capital the business generated, by the way really is to deploy from an M&A perspective in two areas. The first is, and I think the primary of deployment is around competitive and portfolio type acquisitions. And I'll come back to that, the second is in areas where we can expand our capability, Luum an example that. I think your question is kind of about the first. I do think that there are lots of people who are interested in our market. And that should say something to those who fake that. Well, to the extent anyone thinks there won't be growth here, that's a strong evidence in the opposite direction. That having said, our competitive advantage when we looked at the transactions that work for us, Greg, is that I think nobody knows how, no one knows this business better than us and no one knows how to generate synergies, broadly speaking better than us. And we've done it time and time and time, again, from portfolio acquisitions. And on the cost side, certainly, have already done it with WageWorks, if you think about it as a part of product extension type acquisition. So I think we have some real advantages in terms of deploying capital for return, I don't doubt that there are other people who will deploy capital. What I think our investors are interested in is, when we deploy it, are we deploying it to generate a high return for them, and I have every confidence that we're going to identify what we have identified, and we will successfully pursue transaction activity that helps us grow, take advantage of our scale, et cetera and do what we do well, to generate return for you. So that's kind of how I feel about it. Operator: Your next question is from Robert Jones of Goldman Sachs. RobertJones: I guess the question is really just hoping to learn a little bit more about Luum. I guess, just within that, a little bit more around the type of offering, specifically the customer overlap, cross sell opportunity. And then anything you'd be willing to share on just how the economic model is set up with the offering, would be helpful. But yes, just in general, a little bit more on Luum would be great. JonKessler: Ted, why don't I throw this one to you? Is that all right? TedBloomberg: That's great. We were doing rock paper scissors for who would get the Luum question and I won, thanks for the question. We are enormously excited about Luum. Here's the way we think about it operationally, and then I'll turn it back over to Jon to see if he has anything to add strategically. Our commuter business is, by and large, monthly transit passes. When we studied the landscape throughout the last year, as we watched what happened to the commuter business during COVID, we realized that the needs that are critical employers and our most kind of challenging and thoughtful business partners had was for a more holistic solution. Someone that could help them expand the commuter benefit to include daily parking, to include alternative modes of transportation, to include making sure they're junior analysts at Goldman Sachs get home safely if they stay late at night with a connected Uber or Lyft. All of those types of benefits was sort of where the next generation commuter benefit was heading for the most discerning clients. And so then we started going out in the marketplace to figure out whether it made more sense for us to build those incremental capabilities or to acquire them. And we found this amazing company that was like minded, about what the demand were in the marketplace, had already signed up some of the most sort of forward-thinking and critically discerning enterprises in the US as their clients and have worked with those clients to build a model that would work. And we just felt really good that Luum is where the puck is going, commuter. And that's sort of kind of how we intend to deploy it. We do think there are cross-sell opportunities. But really just kind of broadening the commuter value proposition within our own commuter base, there's no league tables like there are with HSA, but we believe we're the largest or near the largest commuter provider in the U S. And we think we have an opportunity to take this awesome kind of incremental solution to those partners and help them kind of in a post-COVID commute environment. So that's sort of the operational answer. Jon, if you want to add -- touch on any of the strategic stuff on top. JonKessler: No, I think that was well put. I'm not sure I would add much to that except to say, Rob, that we felt like -- well, I guess, there's two things. One is we felt like over the next -- really, the remainder of this year, it's almost as though we are, from a member's perspective, reintroducing our commuter business. Now members still have accounts and so forth, and there's not much work for them to do, but they're busy. And at the same time, we know that our customers are reintroducing for lack of better term members to work. And it's funny to think about this way, but for a lot of people, that's a big challenge. And from our perspective, the combination of Luum and our existing commuter benefits product really is the best way to do that. It's the best way to reintroduce people to work from a commuting perspective. There are lots of other issues out there, but on this one, we have the best solution and we have the ability to take that to thousands and thousands of clients over time. And that's a really attractive thing and will serve us well broadly. So when I talked at the beginning of the conversation about tailwinds to headwinds -- no, the other way around, headwinds to tailwinds. I always forget. Commuter has something where it will be great to have tailwinds again. And I think Luum really lets us make the most of those tailwinds. Operator: And our next question is from George Hill of Deutsche Bank. GeorgeHill: I guess, Jon, what I wanted to ask you is that should we think of Luum as white label for deals that might happen in the healthcare space, and I might even ask you what you think of as Luum with health care and talk a little bit more about where you see the M&A white space on the health care side of the business? JonKessler: Well, first of all, if I've got a Luum with healthcare, I'm not going to announce it here. So I'm not going to answer that. But you knew I was going to say that, but I do think that there are elements of this that that are very attractive from a playbook perspective. Luum is not a large company. It is not bringing with it a bunch of sort of legacy revenue, et cetera. And it's a company that has had to, kind of, let's say, unless they live or die, but the right answer probably is innovate, for or not ever get off the ground faced with some very, very unique challenges. And so they've had to come up with some very, very unique solution. And from a kind of the right way to bring in new talent and the right way to bring in, if we're going to do, build buy type things as we add capabilities on the health side, it's exactly how I'd want to do it. I think in general, the white space on healthcare, in my mind, continues to be around the consumers’ role in the financial side of the healthcare. So basically we have not yet cracked the code on helping consumers truly understand everything that's going on with their healthcare finance and making that a process that people, that is not stress causing. And so while that may not be the most interesting thing if you're a managed care organization or the most interesting thing if you're a healthcare provider or the most interesting thing if you're pharma it’s really interesting to us. And I think that reflects the fact that we occupy a very unique position within healthcare and one that we will continue to try and use to drive change in the system. So I guess that's a long way to say, yes, I think it's the kind of playbook we hope to follow in healthcare. And yes, I do think there are opportunities in healthcare and they're likely to be centered around the continued effort that we have to connect health and wealth to assure that consumers, when consumers understand the money side they just make the system better, we see that over and over and over and over again. And so where there's more opportunity there we're going to be ready to do it. GeorgeHill: Jon, if I can have a quick follow up, I guess one thing I would ask about is the selling season that's upcoming. We've started to hear from some benefits consults while there wasn't a lot of movement in calendar '20. Calendar '21 seems to be all for the bang, would love any up to the minute comments you'd be willing to provide around kind of sale and selling season and RFPs? JonKessler: Well, this is going to make Greg and Marco very jealous because they didn't get a second thing. So I'm not sure I can do that at Part B. But Ted, if you wouldn't mind, maybe commenting on what we're seeing kind of from a sales funnel perspective and also in our channel checks with the consultants and so forth? TedBloomberg: And I think what we find echos your channel check as well, right, which is we've seen -- one of the reasons why, as I stated, our results year-to-date or ahead of last year-to-date is in part because some of those slipped RFPs became close sales in the early part of this year. So I would say our findings are pretty consistent with what you're hearing from your benefits, consultant connections and we certainly hope it continues. But thus far, we do feel a little wind at our back early from a volume perspective. GeorgeHill: And Jon, I guess, technically, I didn't answer the first one. So maybe that's my first question. Operator: And your next question is from Sandy Draper with Truist Securities. SandyDraper: And Darcy, I know you're still going to be hanging around but I'm glad it's been great working with you. Just wanted to share that. I think this is one question, Jon. I think this is one question and I'm not sure if it goes to Darcy or if it goes to you, Jon or maybe to Tyson, but I'm going to try to wrap it up. When I think about sort of the puts and takes around impacts to cash flow over the next couple of years outside of like where rates go and what accounts you win. I think about, one, I think it's $26 million in your projections, the merger integration costs. I'm pretty sure that ends at the end of this year. Then you've got commuter is still down 50% and I think we all probably don't ever believe it's going all the way back up. But could you remind us where commuter sort of was and sort of to think about what that lift looks like. And then Tyson, you talked about COBRA being a lift at the end of this year, is there a potentiality that may be going into next year, the year out, that, that drops off? I'm just trying to think about those puts and takes. And as we think about sort of a baseline normalized EBITDA or cash flow number, I'm just thinking about those three buckets. So I think that's one question, but that's my best attempt of bringing it into one. TysonMurdock: I'll start with the one that was just a number in there. I mean, we talked about -- and I think we even talked about in the last call that commuter was about it was 75% run rate revenue business product, and it was profitable and still profitable even being down over 50%. So that's kind of the answer to that point of the question. And you talked about essentially these, I'll call them tailwinds that approve EBITDA or cash flow metric. Certainly, in the long term, as Jon pointed out and we continue to point out, the rates are one of the largest drivers of that. And so even with things like a COBRA lift, middle to latter part of this year around what we need to do as far as COBRA work on notifications and some of the fees we may get from that, if people are able to use that effectively. That will kind of be within the year, but the rate is really the thing that's going to drive that long term margin. Also, the other thing I'd say is just the interchange and sort of normalizing that. I talked about that before as well. We're starting to see that normalize. It's still not quite like pre-COVID levels, and we still have this Q1 sort of normalized quarter to get through before the comp sort of change relative to those pandemic quarters. And I guess the last thing I would say is I've never come out of a pandemic. I'm not sure what the timing will be as far as how everything kind of comes back together, but certainly like seeing some of those rate indicators go up because that means a lot to our business given the amount of assets that we're able to generate in this last season. SandyDraper: And that $26 million, just to confirm, that does, that's the last of the merger integration expenses? TysonMurdock: Yes, that was the other point. Yes, that is. And we're committed that we'll be on budget, and that will be gone relative to the WageWorks acquisition at the end of the year. And Ted is on track to make that happen operationally, and we're tracking it. Operator: And your next question is from Donald Hooker of KeyBanc. DonaldHooker: So I guess maybe just a follow-up there on Sandy's question on cash flow. Just when you look into next year, just to hone our models here, obviously, the balance sheet is much better now with the equity offering. But just to con our models, in terms of CapEx, I'll just kind of keep it to that. What is kind of sort of assumptions around CapEx has been, obviously, nearly one year with the two companies together. And are there any investments you need to make into Luum that might elevate that in the near term? JonKessler: So I'll comment generally and then throw to Tyson to talk through kind of what we're expecting from a CapEx perspective this year. The things that are driving CapEx for us are primarily around the investment that Ted and his team are overseeing in the conversion of our platform to a true API driven microservices environment. The value of doing that -- well, let me back up. The way we're paying for it in the sense of generating sort of bankable return, for lack of a better phrase, is that it's making our development activity occur faster and with less hours and therefore, less costs. And you can see that, to some extent, in what we've released over the last quarter, with PLUM sort of V1 or round one, I guess. And the fact that we've committed to over a dozen new release items over the course of this year, that's what that's about. And that will be something that will pay dividends for us for a long time forward, though, not just in that cost savings, but also when we do transactions, and Luum is an example. While I think we will have a little bit of spend on Luum in the short term, we think that we can get this done a lot more effectively today than we could have gotten it done two years ago. And that will be a great -- if assuming we can do it, that will be a great lesson and it will impact what else we're willing to do because we can integrate more effectively with what we already have. So that's really the bulk of where our investment is going beyond areas like securities and so forth that we all know kind of continue to have to be we have to be keeping up with the big boys, no matter how you want to define big boys on that one. Tyson, you want to speak a little bit to directionally, where we see CapEx this year relative to last? TysonMurdock: I mean it has gone a little bit and it's going to be, let's say, 10% of revenue approximately in that area and all the things that Jon outlined are true. I mean we're going to -- and those investments in technology really the thing that's driving that. And so we've got our foot on the gas there to make those improvements, and also tracking what we think the returns will be as well to that. So excited to get that done and really upgrade our technology. Operator: And your next question is from Stephanie Davis of SVB Leerink. StephanieDavis: Darcy, obviously, a very well deserved move, but you will be so very, very missed. But since you're transitioning from that CFO seat, I think I’ll ask Tyson about my guidance question. So not a bad time move. DarcyMott: He's getting used to it. StephanieDavis: So from the press release, it sounds like you guys are executing well on wage energies. There's $20 million more coming this year, but profitability did look a little bit soft in the guidance. Is this a function of the expectations for a strong selling season, which was talked about in the prepared remarks, would that cost kind of offsetting the wage savings, is it some of the investments you've talked about before, or is there really anything else to call out, maybe some conservatism in the back to work assumptions? TysonMurdock: Yes. I think Stephanie, where I would go with this is it's really -- you go back to the rates and where we generate big part of our profitability is when those rates start to improve. And of course, you now see what Darcy announced, we're close to 200 bps for the quarter, but it will be 175 bps for the annual period, and you have seen that, as you track closely, you've seen that come down over the course of the decline in interest rates. And so when I think about that, that's really one of the things that tempers that margin improvement. Now things get commuter come back if we get some of that, those dollars back up to that $75 million, I think Luum helps us potentially do that. That's not included in there because I haven't seen that happen, and it's something that if I were to think it's going to happen, it would maybe be in the latter half of the year. And when I see some movement there, we'll, of course, talk about that. And that's one of the things that's tempered that a lot. I mean Luum won't really add anything from a margin perspective. It's a start up with minimal revenue and really, it's reinvesting that back into the business. And so you don't get much there. And so those are kind of the top three things that I would think really is the reason why we're kind of where we're at. And I think we've got a good end of the year and being consistent with that and what we're trying to push is pretty good, and gives us a good base to come off of. StephanieDavis: And then one quick follow-up, Jon. I need to hear how you definitively know that Darcy drives the fastest car in the lot, very important. Thank you. JonKessler: He's taken me in it. And if it's -- let's put it this way. If it's not the fastest car on the lot, the fastest car is very well hit. I'm pretty sure that everyone in -- and by the way, it's not the first, right? This is -- he used to have the fastest one, and he got a faster one. So we're talking -- but for those who are concerned about the environment, I believe it's a hybrid of some sort. So it's not one of them Teslas. It's some kind of other car. That's a hybrid of some sort. So he's running fast, but he's running clean. Operator: Your next question is from David Larsen of BTIG. DavidLarsen: Can you talk a little bit about how Luum is priced? Like, I mean, does the revenue coming from Luum depend on people actually commuting to work, or is it more of a subscription sort of model. And let's say, half of your customers were to purchase Luum, what sort of revenue run rate could you get to, let's say, five years from now? Could it bring you up to $75 million five years from now? Just any color around that would be very helpful. JonKessler: Yes. I'll give this one a shot and then ask Ted to add to it. Maybe he'll have the coherent part. Luum's primary business is a subscription-type business. So somewhat similar to the core of COBRA, where it's dependent on the number of team members or employees you have as opposed to who's driving or what have you. And that's because the solution has something to offer for kind of everybody. So one item, for example, that Ted hasn't touched on is or didn't touch on in this conversation is that is the opportunity to help employers to the extent that we see, for example, work-from-home cost reimbursement mandates coming out. Luum has some capabilities in that area. That, again, sort of like the theory is it's being there for every commute or no commute at all. And so that's how Luum is priced. And so it does provide in the broader Commuter business, some stability related to variability in commuting. I don't know that I have done the calculation you asked for. And so I would not want to do it on the fly. But I will say that what I think I'll say one other thing, which is I think what's particularly interesting also about Luum is that it can make a meaningful contribution to the return of this Commuter business. I mean one thing I might have said in response to Greg's question is one thing I like about this transaction from the perspective of our shareholders is, I am absolutely certain that it will yield, or as certain as I can be, that it will yield material return expressed in terms of IRR or return on invested capital or what have you, for our shareholders. I'm certain of that. Whether the percentage will be big and the numbers won't, is to be seen. But the IRR is going to work here. And I think one reason for that, as your comment suggests, is that there are a lot of clients who really never had to think about these issues and never thought about commuter benefits because most of their people were either driving solo or driving in car pools or whatever. But now with return to work, some of the examples Ted offered, there are things to think about. And then with ESG and all of that. I don't think anyone wants the outcome of the pandemic to be that we all abandon alternative commute modes and everyone drives to work alone. So there's that, too I think about, for example, Luum has a solution for closed-loop car pool reservation, so that if let's say, you have a staggered work schedule and you want to do car pooling only with people on your work schedule. That's the kind of thing that you can do with Luum. And So I think those are really neat, the kinds of things that folks who are out there in hungry and really focus do. And we're happy to bring that solution to a much larger audience. DavidLarsen: And then just one more quick one. With the synergies from wage, you're going to be, I think, $80 million by the end of fiscal '22. And so should we expect to see a pretty sizable increase in adjusted EBITDA in fiscal '23, assuming that there's some improvement in yield, and at a minimum, Commuter doesn't get worse. Because it's like there's very modest adjusted EBITDA growth from '21 to '22. JonKessler: I mean we're not giving guidance here, but I would sure hope so. Operator: And your next question is from Mark Marcon of Baird. MarkMarcon: And Darcy, congratulations. It's been truly a pleasure working with you since the IPO. And you will be missed, but it's been fantastic, and hope we can stay in contact. I mean what you've done has been remarkable. And I thought Jon said it incredibly well, but it really is something. Questions on Luum. I'm just wondering, as you're thinking about it -- first of all, how much of a contribution will it make for this year? And any sort of parameters that you can give us in terms of a revenue expectation and EBIT, EBITDA margin expectation. Just any sort of framing of just the current size? I know it's small. And then strategically, what I'm wondering is to what extent is there an opportunity to sell it as a stand-alone being additive to your existing client base? And to what extent will it end up helping you in RFPs from a commuter perspective, but also to greater differentiate all of your CDB offerings on a holistic manner where you're really showing, hey, we're really being forward-thinking in terms of being comprehensive and holistic with regards to our solutions and thinking about areas that are going to be important in the future. JonKessler: Ted, why don't you take the second half of that question? And then we'll come back to Tyson for the first. TedBloomberg: We have high hopes for Luum's ability to, a, be added to our existing many thousands of commuter clients. Not all of them. There will be certain types of clients that will lend themselves more to a more comprehensive solution like Luum is offering, but that's definitely one of our deal hypothesis, and we're pretty excited about it. And then we would kind of concur with your implied assessment, which is that in the RFP process as we're deepening our distribution relationships, being able to offer something as part of the benefits package that really no one else can, we think will help, right? Exactly how much it will help an HSA sale, we don't know, but we think it will get us into more conversations. It will make our RFP responses stand out a little bit. Our preliminary conversations with both clients and prospective clients have definitely been a lot of sort of, I'm intrigued, tell me more, which has been excited and we're just kind of getting warmed up. The Luum team, they are exceptional. They're thoughtful, go-to-market people. And they have some great ideas, and we have some great ideas, and we're looking forward to putting it together, and we feel pretty optimistic about it. I'll turn it over to Tyson to answer your economic question. TysonMurdock: Mark, it's small and it doesn't drive margin, but there's upside, I think if you go take a look at their website and you see what kind of clients and partnerships they have, you know there's a good market check there on who they're working with. And I think there's a nice opportunity there to support us kind of cling back through getting the commuter business back through because I think it's going to sync up nicely with that because of the way the cards integrate and those type of things, but it's small from a revenue perspective to begin with. JonKessler: I'll say one other thing about this and not to pile longer, but the team are accomplished guys. They've been -- and -- well, I was using the term guys colloquially. It's an accomplished team, so did real and his team did real stuff at Microsoft, and then really saw this area as an area that they felt passionate about. And what's really underneath it is a passion for engagement and using the employee relationship as a way to drive engagement. So they're actually underneath the covers, a lot of talent commonalities and a lot of sort of philosophical commonalities among our teams. The focus on engagement, the use of technology to drive that engagement the opportunity to do well while doing good. And so it really felt like a good fit and as sort of the first of this type of transaction that we've ever done as well as a public company, like something we could do that would work for investors and that would give us a lot of room to grow and explore and be successful together. Operator: And your next question is from Sean Dodge of RBC Capital Markets. SeanDodge: So Tyson, you said a couple of times now rates are one of the bigger kind of long term swing factors for margins. And Jon, you said accurately noted the rise in 10 years that we've seen, you said yields probably don't impact you much this year but maybe could, should future years. Can you just walk us through how quick and to what extent do these moves typically flow through to you all? I know it takes some time to affect the instruments your benchmarks. And the I guess, how often are you placing new cash? Is it only annually? And then you ladder it in three, four years. So every year, you've got some rolling off two that's being replaced. But I guess, maybe just a quick reeducation just given maybe for the first time while there's something to be encouraged about on the kind of the rate outlook. DarcyMott: We generally ladder things and most of our placements occur in the kind of the December, January time frame. So when Tyson guided that our rates were 175 it’s because most of the money that we anticipate this year is already -- we have deposit agreements in place to take care of that. Because of the wage migration this past year, we did enter into some newer contracts more midyear than we normally would. And so when those start rolling off in the future, there might be a little bit more midyear movement. But on the other hand, we're always looking for opportunities of getting yield enhancement. And so some of these contracts have some ability to move between contracts because they have mins and maxes, et cetera. So if the rate environment starts increasing, that would be helpful. But as we said on the call, most of that benefit will come to next year based on placements that we do in December and January. Does that make sense? Operator: And your next question is from Allen Lutz of Bank of America. AllenLutz: I guess to follow-up there, the two year treasury is only at about 15 basis points, and the five year has backed up, I think, is kind of what you were mentioning at the top of the call to almost 1% or about 85 basis points. So there's a big spread between the two year and the five year. I guess when you kind of talk about the optimism that you had, is that just based off of the treasury curve movement being a potential precursor to improvements in CDs, or are you actually having more positive conversations with depository institutions about where you could place rates? JonKessler: Well, this is a little bit of a quiet period in terms of our conversations because not using that term in its legal sense. But because we've done a lot of placement over the course of December and January. But I will say, during that period, as we got into January, things did firm up quite a bit. And as to what we're talking about now is really to some extent, we're previewing with our, I believe it's 20 partners, what our needs are going to be for next year. And so there's been a ton of interest in that. I think that interest is bounded primarily by questions on the part of different depository partners about what loan volume is going to be, and in particular, and what duration that loan volume is going to come from. So I can't say there aren't questions, but I do think that the conversations certainly relative to what we were seeing when we were having the same conversations last March and April, that was tough. This is better. So obviously, a ways to go this year, but the fact that we're talking about reflation and that we're seeing evidence of reflation that we've seen about 50% of the jobs lost have come back is are all good things broadly for this company and for our opportunity on placement. AllenLutz: And then the revenue increase, about $10 million since we spoke a few weeks ago. I guess is there any way you can break out sort of where that improvement is coming from? Is it related to COBRA, from loom, more confidence on the reopening? Just if you could kind of bucket that for us. JonKessler: Tyson, I don't think we're going to bucket it, but I don't think we're going to break it out too much. But Tyson, why don't you give some color on it? TysonMurdock: I mean where we started on this is we promised we grow top line growth if we have the opportunity here post COVID and because we raised it, we thought we did, right? And I think you did mention the things that we're talking about. I mean, there's certainly still the Q4 challenges that we faced, revenue was still down every category in Q4 to Q4. So we're still in these COVID quarters. We still have that Q1. It will be sort of in a similar vein. That's right. We'll work through COBRA. We're going to -- over the last part of the year, we're going to get something from that. Certainly, Luum provides a little bit, like I said before, though, it's small. But I think the upside on that is there's potential. And it's not something that we necessarily have to wait for season, like the rest of our business. So maybe, again, in the latter half of the year, we get some upside from that. And then I think, overall, again, it's sort of that mixing that bag up with -- we're thinking about things like an increasing commuter maybe in the last part of the year a little bit, right, but not very much. You see some of -- I'm watching the news like everybody else. And looking forward to getting vaccinated. And maybe that changes the way people move around a little bit relative to what we've been seeing, which just hasn't moved at this point. So it is those things. Operator: There are no further questions at this time. I would like to turn the conference over to Jon for closing remarks. Jon Kessler: Yes. Thanks, everyone, again, for joining us. Please, I know things are getting better, but let's all just stay safe and sane. One more comment on Darcy. Darcy is a Dodgers fan. And while I'm not sure I'm as keen on bleeding blue as purple, I would note this, which is that I believe it's the case that the highest batting percentage among any Dodger, of Brooklyn or Los Angeles, is Willie Keeler. And I think 352, maybe 356. So Darcy is not only an intra two taller than Willie Keeler. But beyond that, he is leaving this role, I believe, I may be wrong about this, but I believe he's adding 1,000 in terms of meeting your earnings expectations on a quarterly basis. And as I suggested in my earlier remarks, that kind of stability and ability to look around corners and to make promises that you can deliver on is something that is Darcy's unique and strong contribution to our culture. And though he will not be in this role. That part of his legacy is going -- I want to assure you that, that part of his legacy will be part of Purple culture going forward to the extent that anyone on this call has anything to say about it. So we look forward to meeting and beating in a quarter and a quarter after that and a quarter after that. And with that, thank you guys very much. Darcy Mott: Thank you, Jon. Have a great time. Jon Kessler: Okay. Bye-bye, buddy. Well, go ahead. Operator: And this concludes today's conference.HQY Ratings Summary
HQY Quant Ranking
Related Analysis
HealthEquity’s Price Target Increased at KeyBanc
KeyBanc analysts increased their price target on HealthEquity (NASDAQ:HQY) to $95 from $85, keeping an Overweight rating.
The analysts shared insights from a recent conference with HealthEquity's management, coming after the company reported impressive earnings, particularly in terms of profitability. The analysts adjusted estimates upward, considering higher custodial yields, with enhanced rate products now exceeding 30% and expected to rise to around 60% by 2027 or sooner.
The analysts believe HealthEquity is strategically positioned for growth by expanding its share in the Health Savings Accounts market, both organically and through strategic acquisitions, enhancing its rate business, and utilizing AI to bolster its financial performance.
The analysts argued that the company's high-margin HSA assets, which contribute to a strong cash position, justify the potential for multiple expansion, supporting his Overweight rating.
HealthEquity Stock Soars 11% on Better Than Expected Q1 Results
HealthEquity (NASDAQ:HQY) shares gained more than 11% intra-day today after the company reported its Q1 earnings results, with revenue coming in at $244.4 million, better than the Street estimate of $239.39 million. EPS was $0.50, beating the Street estimate of $0.41.
For fiscal 2024, the company expects EPS to be in the range of $1.88-$1.97, compared to the Street estimate of $1.77, and revenue in the range of $975-$985 million, compared to the Street estimate of $968 million.
While the interest rate outlook continues to be the primary force driving both EBITDA & shares, analysts at RBC Capital see encouraging improvement across other fundamentals as well, including (1) continued progress driving increased adoption of the company's enhanced yield offerings, (2) benefits of automation driving lower service costs, and (3) increasing traction adding new clients.
HealthEquity Stock Soars 11% on Better Than Expected Q1 Results
HealthEquity (NASDAQ:HQY) shares gained more than 11% intra-day today after the company reported its Q1 earnings results, with revenue coming in at $244.4 million, better than the Street estimate of $239.39 million. EPS was $0.50, beating the Street estimate of $0.41.
For fiscal 2024, the company expects EPS to be in the range of $1.88-$1.97, compared to the Street estimate of $1.77, and revenue in the range of $975-$985 million, compared to the Street estimate of $968 million.
While the interest rate outlook continues to be the primary force driving both EBITDA & shares, analysts at RBC Capital see encouraging improvement across other fundamentals as well, including (1) continued progress driving increased adoption of the company's enhanced yield offerings, (2) benefits of automation driving lower service costs, and (3) increasing traction adding new clients.
HealthEquity Shares Dropped 23% Following Q3 Results
HealthEquity, Inc. (NASDAQ:HQY) shares were trading more than 23% lower Tuesday morning, following the company’s reported Q3 results, with revenues coming in at $180 million, below the consensus estimate of $184 million. This was driven primarily by weakness in service revenue as the number of CDBs declined sequentially across FSAs, commuter, and COBRA.
In addition, the company provided a downward guidance revision, which likely caught most people by surprise, however, the strength in the core HSA business appears to be continuing into year-end.
According to the analysts at RBC Capital, the significant share price drop following the “by no means great quarter” is a pretty strong over-reaction.
